Spatial structure governs the mode of tumour evolution

Characterizing the mode – the way, manner, or pattern – of evolution in tumours is important for clinical forecasting and optimizing cancer treatment. DNA sequencing studies have inferred various modes, including branching, punctuated and neutral evolution, but it is unclear why a particular pattern predominates in any given tumour [1]. Here we propose that differences in tumour architecture alone can explain the variety of observed patterns. We examine this hypothesis using spatially explicit population genetic models and demonstrate that, within biologically relevant parameter ranges, tumours are expected to exhibit diverse evolutionary modes including four archetypal “oncoevotypes”: rapid clonal expansion (predicted in leukaemia); progressive diversification (in colorectal adenomas and early-stage colorectal carcinomas); branching evolution (in invasive glandular tumours); and almost neutral evolution (in certain non-glandular and poorly differentiated solid tumours). We thus provide a simple, mechanistic explanation for a wide range of empirical observations. Oncoevotypes are driven by differences in cell dispersal and cell-cell interactions, which we show are essential for accurately characterizing, forecasting and controlling tumour evolution.

[1]  Xuemei Lu,et al.  Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution , 2015, Proceedings of the National Academy of Sciences.

[2]  Marc J. Williams,et al.  Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.

[3]  Martin A. Nowak,et al.  A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity , 2015, Nature.

[4]  James S. Lawson,et al.  Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV) , 2018, Front. Oncol..

[5]  Oskar Hallatschek,et al.  Excess of mutational jackpot events in expanding populations revealed by spatial Luria–Delbrück experiments , 2016, Nature Communications.

[6]  Ville Mustonen,et al.  The evolutionary landscape of colorectal tumorigenesis , 2018, Nature Ecology & Evolution.

[7]  Andrea Sottoriva,et al.  Between-Region Genetic Divergence Reflects the Mode and Tempo of Tumor Evolution , 2017, Nature Genetics.

[8]  S. Peischl,et al.  Range Expansion Theories Could Shed Light on the Spatial Structure of Intra-tumour Heterogeneity , 2018, Bulletin of Mathematical Biology.

[9]  R. Durrett,et al.  Spatial Moran models, II: cancer initiation in spatially structured tissue , 2016, Journal of mathematical biology.

[10]  T. Tsuzuki,et al.  Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma. , 2013, American journal of clinical pathology.

[11]  H. Levine,et al.  Clinical Medicine , 1997 .

[12]  D. Welsh,et al.  A Two‐Dimensional Poisson Growth Process , 1965 .

[13]  Peter Bankhead,et al.  QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.

[14]  C. Curtis,et al.  A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.

[15]  Nicholas Navin,et al.  Tumor evolution: Linear, branching, neutral or punctuated? , 2017, Biochimica et biophysica acta. Reviews on cancer.

[16]  Oskar Hallatschek,et al.  Gene surfing in expanding populations. , 2007, Theoretical population biology.

[17]  B. Klink,et al.  Patterns of Tumor Progression Predict Small and Tissue-Specific Tumor-Originating Niches , 2018, bioRxiv.

[18]  T. Williams,et al.  Stochastic Model for Abnormal Clone Spread through Epithelial Basal Layer , 1972, Nature.

[19]  B. Benayoun,et al.  The forkhead factor FOXL2: a novel tumor suppressor? , 2010, Biochimica et biophysica acta.

[20]  H. Ohtsuki,et al.  Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.

[21]  Zoltan Szallasi,et al.  Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal , 2018, Cell.

[22]  R. Durrett Branching Process Models of Cancer , 2015 .

[23]  M. Baccarani,et al.  Chronic myeloid leukaemia , 2007, The Lancet.

[24]  Robert Noble,et al.  Spatial competition constrains resistance to targeted cancer therapy , 2017, Nature Communications.

[25]  Joel s. Brown,et al.  Classifying the evolutionary and ecological features of neoplasms , 2017, Nature Reviews Cancer.

[26]  Anders Isaksson,et al.  Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer , 2018, Nature Genetics.

[27]  Carlo C. Maley,et al.  Clonal evolution in cancer , 2012, Nature.

[28]  D. Prapotnich,et al.  Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems , 2018, The American journal of surgical pathology.

[29]  W. Bodmer,et al.  Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. , 2003, Cancer research.

[30]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[31]  Jan Poleszczuk,et al.  In Silico Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer. , 2017, Cancer research.

[32]  Sarah Ng,et al.  Multiregion ultra‐deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer , 2016, Molecular oncology.

[33]  Benjamin J. Raphael,et al.  Neutral tumor evolution? , 2017, Nature Genetics.

[34]  Robert A Gatenby,et al.  Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies , 2017, bioRxiv.

[35]  Zafarali Ahmed,et al.  Intratumor Heterogeneity and Circulating Tumor Cell Clusters , 2017, bioRxiv.

[36]  A. Flecker,et al.  Riparian plant litter quality increases with latitude , 2017, Scientific Reports.

[37]  Marc J. Williams,et al.  Quantification of subclonal selection in cancer from bulk sequencing data , 2018, Nature Genetics.

[38]  Hans Clevers,et al.  Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem Cells , 2010, Cell.

[39]  S. Roberts,et al.  Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. , 1992, Gut.

[40]  D. Gillespie Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .

[41]  Andreas Hochhaus,et al.  Chronic myeloid leukaemia , 2007, The Lancet.

[42]  C. Curtis,et al.  Big Bang Tumor Growth and Clonal Evolution. , 2018, Cold Spring Harbor perspectives in medicine.

[43]  Joel s. Brown,et al.  Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces. , 2016, Cancer research.

[44]  Oskar Hallatschek,et al.  Genealogies of rapidly adapting populations , 2012, Proceedings of the National Academy of Sciences.

[45]  C. Swanton,et al.  Resolving genetic heterogeneity in cancer , 2019, Nature Reviews Genetics.